HomeWebcastDefective Drugs and Medical Devices: Understanding Mass Tort Litigation in the 2017 Landscape
Online CLE Defective Drugs CLE

Defective Drugs and Medical Devices: Understanding Mass Tort Litigation in the 2017 Landscape

Live Webcast Date: Friday, August 11, 2017 from 3:00 pm to 4:30 pm (ET)
CLE LitigationCLE TortRecording

Online CLE Defective Drugs

Join us for this Knowledge Group Online CLE Defective Drugs Webinar. Pharmaceutical and medical device manufacturers, hospitals and healthcare providers increasingly find themselves in the crosshairs of mass tort litigation. Claims involving alleged defective drugs and medical devices are often surrounded by a multitude of complex issues, such as discovery and personal jurisdiction issues, which require a defense counsel's thorough knowledge and understanding.

Our panel of key thought leaders and practitioners will provide an overview of the latest trends and developments in mass tort litigation involving defective drugs and medical devices. They will help the audience learn strategic approach in establishing defense in light of these trends and other complex issues that surround mass tort claims.

Key topics include:

  • Steps to Take to Ensure Proportionality in Discovery
  • Utilizing Technology to Control the Data Instead of Letting the Data Control You
  • Effective Strategies for Identification and Retention of Expert Witnesses
  • Understanding and Addressing Regulatory Compliance Issue and Their Role in Litigation
  • How to Use the Quality System to Your Client’s Best Advantage
  • June 2017 Supreme Court opinion: Bristol-Myers Squibb v. Superior Court of California, No. 16-466
    • Case Background
    • The Decision
    • Practical Implications for Plaintiffs

Agenda

SEGMENT 1:
Douglas B. KingPartner
Wooden McLaughlin
AND
James M. BoyersPartner
Wooden McLaughlin

  • Steps to Take to Ensure Proportionality in Discovery
  • Utilizing Technology to Control the Data Instead of Letting the Data Control You
  • Effective Strategies for Identification and Retention of Expert Witnesses
  • Understanding and Addressing Regulatory Compliance Issue and Their Role in Litigation
  • How to Use the Quality System to Your Client’s Best Advantage

SEGMENT 2:
Brady WilliamsSenior Associate Attorney
Van Wey Law, P.L.L.C.

  • June 2017 Supreme Court opinion: Bristol-Myers Squibb v. Superior Court of California, No. 16-466
    • Case Background
    • The Decision
    • Practical Implications for Plaintiffs

Who Should Attend

  • FDA Attorneys
  • Mass Tort Litigation Attorneys
  • Class Action Litigators
  • Trial Lawyers
  • Corporate Counsel
  • In-house Counsel
  • Medical Device Manufacturers
  • Drug Manufacturing Executives
  • Professionals from Food and Drug Industries
  • Professionals from Medical Device Industries

Online CLE Defective Drugs

SEGMENT 1:
Douglas B. KingPartner
Wooden McLaughlin
AND
James M. BoyersPartner
Wooden McLaughlin

  • Steps to Take to Ensure Proportionality in Discovery
  • Utilizing Technology to Control the Data Instead of Letting the Data Control You
  • Effective Strategies for Identification and Retention of Expert Witnesses
  • Understanding and Addressing Regulatory Compliance Issue and Their Role in Litigation
  • How to Use the Quality System to Your Client’s Best Advantage

SEGMENT 2:
Brady WilliamsSenior Associate Attorney
Van Wey Law, P.L.L.C.

  • June 2017 Supreme Court opinion: Bristol-Myers Squibb v. Superior Court of California, No. 16-466
    • Case Background
    • The Decision
    • Practical Implications for Plaintiffs

Online CLE Defective Drugs

Online CLE Defective Drugs

Douglas B. KingPartnerWooden McLaughlin

Douglas B. King is a partner at Indianapolis based Wooden & McLaughlin LLP. In his 40+ year civil litigation based practice, he has defended and tried numerous drug and medical device product liability cases. His trial and appellate work has yielded landmark cases and over thirty published decisions. Doug is a Fellow in the American College of Trial Lawyers, International Association of Defense Counsel and Litigation Counsel of America. Peer recognitions include 2003 Indiana Defense Lawyer of the Year; 2013-2016 "Best Lawyers in America" Mass Tort/Class Actions Defense; 2004-2017 Indiana Super Lawyers; Chambers USA 2017.

Online CLE Defective Drugs

James M. BoyersPartnerWooden McLaughlin

James M. Boyers is a partner at Indianapolis based Wooden & McLaughlin LLP. His trial and appellate practice has a substantial focus on product liability and mass torts involving medical devices. His mass tort work has included dealing with a wide range of E-Discovery issues including European Data Privacy, Production Protocols and Managing Document Reviews. Jim recently passed the four hour examination for the Association of Certified Electronic Discovery Specialists (ACEDS).

Online CLE Defective Drugs

Brady WilliamsSenior Associate AttorneyVan Wey Law, P.L.L.C.

Brady has spent his legal career representing injured individuals in high-stakes litigation throughout the country. The cornerstone of his practice is a client-first approach that ensures every decision he makes is tailored to provide aggressive and dedicated representation. His consistent winning results prove the value of his uniquely attentive approach.

Before joining Van Wey Law, Brady practiced in California with one of the nation’s most successful mass tort law firms. Licensed to practice in Texas and California, his practice remains dedicated to helping clients in cases involving medical malpractice and other catastrophic injuries while also representing individuals throughout the country in multi-million dollar pharmaceutical and medical device litigations.  

Online CLE Defective Drugs

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   Experience in healthcare Law

Course Code:
   146496

NASBA Field of Study:
   Finance - Technical

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    1.5 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Founded in 1970, Wooden & McLaughlin LLP offers its clients a high level of experience, knowledge, accessibility and responsiveness. Before 1970, Bill Wooden and Robert McLaughlin were partners at another Indiana law firm. Because they were concerned that client responsiveness and attention would suffer if their firm became too large, they decided to form a new firm. Wooden & McLaughlin was formed with the idea that a law firm should strive to exceed commonly accepted standards of professionalism and client service while providing unsurpassed legal representation. The firm continues to build upon that tradition today.

Website: https://woodenmclaughlin.com/

The attorneys and staff at Van Wey Law are dedicated to treating each client with dignity and respect and affording each person the individualized attention they deserve. The team members are caring and compassionate professionals who have first-hand experience of pain and loss in our own lives. They are able to relate to their clients thus making them become part of the firm family. The entire team is laser focused on achieving results for their clients that serve a purpose of “righting wrongs” by restoring dignity and assuring financial peace of mind.  

Douglas B. King is a partner at Indianapolis based Wooden & McLaughlin LLP. In his 40+ year civil litigation based practice, he has defended and tried numerous drug and medical device product liability cases. His trial and appellate work has yielded landmark cases and over thirty published decisions. Doug is a Fellow in the American College of Trial Lawyers, International Association of Defense Counsel and Litigation Counsel of America. Peer recognitions include 2003 Indiana Defense Lawyer of the Year; 2013-2016 "Best Lawyers in America" Mass Tort/Class Actions Defense; 2004-2017 Indiana Super Lawyers; Chambers USA 2017.

James M. Boyers is a partner at Indianapolis based Wooden & McLaughlin LLP. His trial and appellate practice has a substantial focus on product liability and mass torts involving medical devices. His mass tort work has included dealing with a wide range of E-Discovery issues including European Data Privacy, Production Protocols and Managing Document Reviews. Jim recently passed the four hour examination for the Association of Certified Electronic Discovery Specialists (ACEDS).

Brady has spent his legal career representing injured individuals in high-stakes litigation throughout the country. The cornerstone of his practice is a client-first approach that ensures every decision he makes is tailored to provide aggressive and dedicated representation. His consistent winning results prove the value of his uniquely attentive approach.

Before joining Van Wey Law, Brady practiced in California with one of the nation’s most successful mass tort law firms. Licensed to practice in Texas and California, his practice remains dedicated to helping clients in cases involving medical malpractice and other catastrophic injuries while also representing individuals throughout the country in multi-million dollar pharmaceutical and medical device litigations.  

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199